Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Some may also qualify for manufacturer discounts
In today's fast-evolving weight management space, finding a natural alternative to the popular GLP-1 agonists is on everyone's radar
However, please keep in mind everyone has different tolerances to caffeine
Eli Lilly and Company MarketRank Stock Analysis Overall MarketRank 92nd Percentile Analyst Rating Moderate Buy Upside/Downside 11.7% Upside Short Interest Level Bearish Dividend Strength Strong News Sentiment 1.02 Insider Trading N/A Proj
L.YeongY
Data were analyzed using Prism version 6.05 software (Graph Pad, San Diego, California)
US$ 25.04
US$ 26.89
US$ 27.81
US$ 27.87
US$ 29.67
US$ 21.71
